Claybrook Capital’s Eastman Chemical EMN Stock Holding History

Claybrook Capital’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-157	Closed	-$11K	–	261
2018 Q4	$11K	Buy	+157	New	+$12.5K	﹤0.01%	457

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Claybrook Capital's EMN Position: Q1 2019 in Review

Claybrook Capital sold out of Eastman Chemical (EMN) in Q1 2019, closing a stake of 157 shares — an estimated $11K sold.

Claybrook Capital first reported a position in EMN in Q4 2018 and held it in 1 quarter. The position peaked at $11K in Q4 2018. 695 funds tracked by Wall St. Rank hold EMN as of Q1 2019.

Claybrook Capital reported no remaining Eastman Chemical position as of Q1 2019 after selling out during the quarter.
Claybrook Capital sold 157 Eastman Chemical shares in Q1 2019, an estimated $11K.
Claybrook Capital first reported a position in Eastman Chemical in Q4 2018 and held it in 1 quarter.
Claybrook Capital's Eastman Chemical position peaked at $11K in Q4 2018.
695 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2019.

Based on Claybrook Capital's 13F filing for Q1 2019, filed 15 May 2019.